Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL27584077

BrCc1cccc2cc[nH]c12.CC(C)(C)OC=O

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 1/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ BCHE P06276 3/20 0.39
▸ NR3C1 P04150 1/20 0.38
▸ PGR P06401 1/20 0.38
▸ NR3C2 P08235 1/20 0.38
▸ AR P10275 1/20 0.38
▸ BACE1 P56817 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.36
▸ AHR P35869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL27800467 0.89 HTR2A (0.41) HTR2AHTR2CBCHENR3C1PGR
SCHEMBL2399846 0.82 AHR (0.50) HTR2AHTR2CNR3C1PGRNR3C2
Tert-Butyl Formate SCHEMBL27601710 0.81 TDP1 (0.34) TDP1
Tert-Butyl Formate SCHEMBL27584070 0.80 TDP1 (0.33) TDP1AHR
Tert-Butyl Formate SCHEMBL27584058 0.80 NR3C1 (0.42) BCHENR3C1PGRNR3C2AR
Tert-Butyl Formate SCHEMBL27751459 0.78 AHR (0.64) BCHENR3C1PGRNR3C2AR
SCHEMBL27743076 0.73 BACE1 (0.42) HTR2AHTR2CBCHENR3C1PGR
SCHEMBL14256041 0.73 AHR (0.42) HTR2AHTR2CBCHENR3C1PGR
SCHEMBL593512 0.71 AHR (0.50) BCHENR3C1PGRNR3C2AR
Indole SCHEMBL27701507 0.71 CA1 (0.59) NR3C1PGRNR3C2ARTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101214248-A Triazolo[4,5-d] pyrimidine derivatives and their application as purinergic receptor antagonists VERNALIS RES LTD (GB) 2008-07-09 — — CN disclosed
CN-1496262-A Triazolo [4, 5-d ] pyrimidine derivatives and their use as purinergic receptor antagonists О 2004-05-12 — — CN disclosed
Send feedback